KEROS THERAPEUTICS INC
KROSNASDAQ🏆 #3023 by market capEarnings Nov 4US Equity
$10.72▲ $0.05 (+0.42%)
Live1h▲ 0.0%
24h▲ 0.4%
7d▲ 7.3%
14d▲ 7.9%
30d▼ 3.6%
1y▼ 21.9%
🏦Market Cap
$343M
Small Cap
📈Revenue Growth (YoY)
+6775.0%
High Growth
📊Gross Margin
94.7%
High
💵FCF Margin
-322.9%
Thin
⚖️P/S Ratio
22.7x
Expensive
Otter Score
44
Weak
Earnings
Q3 · 2026Reported 2026-08-03Earnings Per Share
Actual
-1.45
Expected
-1.34
miss
−8.20%
YoY −90.80%
Revenue
Actual
—
Expected
$807.14K
—
—
Consensus estimates
Recent quarters
Q3 2026
-1.45
miss
Q2 2026
-1.21
miss
Q1 2026
-0.86
miss
Q4 2025
-0.18
beat